Xencor Inc

NASDAQ:XNCR  
39.65
-0.07 (-0.18%)
Products

Biocytogen Have Reached Agreement With Xencor, Inc., For Licensing Of Co's Fully Human Antibody Renmab/Renlite

Published: 12/07/2020 20:08 GMT
Xencor Inc (XNCR) - Biocytogen - Have Reached Agreement With Xencor, Inc., for Licensing of Co's Fully Human Antibody Renmab/renlite.